drugset / Trial / NCT04769687
Symbiotics and Systemic Inflammation in Chronic Kidney Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
Main objective: To assess the effectiveness of treatment with symbiotics on the chronic systemic inflammation observed in chronic renal failure 4 months after the start of treatment.
Timeline
- Start
- 2020-11-21
- Primary completion
- 2023-05-01
- Completion
- 2023-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Orafti®Synergy1 | Unknown | 5 g | Oral |
| Subject | Vivomixx | Other / unclassified | 4.5e+11 cells | Oral |